| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
28,457 |
14,620 |
$1.56M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,074 |
7,226 |
$66K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,424 |
7,682 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,562 |
3,635 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,469 |
1,830 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21 |
21 |
$2K |
| 90651 |
|
204 |
188 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,947 |
1,085 |
$1K |
| 99215 |
Prolong outpt/office vis |
31 |
30 |
$1K |
| 82947 |
|
3,115 |
1,799 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,307 |
1,941 |
$1K |
| 92552 |
|
295 |
250 |
$1K |
| 90633 |
|
213 |
195 |
$944.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,872 |
1,511 |
$839.12 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
252 |
200 |
$784.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,801 |
1,567 |
$646.32 |
| 99173 |
|
1,352 |
934 |
$519.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,150 |
1,857 |
$498.45 |
| 81002 |
|
2,170 |
1,220 |
$472.71 |
| 90688 |
|
27 |
27 |
$364.80 |
| J1020 |
Injection, methylprednisolone acetate, 20 mg |
214 |
145 |
$352.12 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
908 |
619 |
$343.91 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
926 |
560 |
$256.96 |
| 90734 |
|
32 |
29 |
$224.00 |
| 90707 |
|
16 |
14 |
$112.00 |
| 90716 |
|
16 |
14 |
$112.00 |
| 87807 |
|
142 |
99 |
$66.72 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
155 |
75 |
$25.00 |
| 90686 |
|
89 |
34 |
$20.53 |
| 36415 |
Collection of venous blood by venipuncture |
2,547 |
1,301 |
$13.80 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
426 |
219 |
$4.26 |
| 3078F |
|
1,476 |
1,299 |
$0.00 |
| 3077F |
|
275 |
253 |
$0.00 |
| 81025 |
|
349 |
187 |
$0.00 |
| 90461 |
|
403 |
75 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
257 |
129 |
$0.00 |
| 83655 |
|
69 |
60 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
104 |
80 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
57 |
15 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
891 |
160 |
$0.00 |
| 90658 |
|
70 |
12 |
$0.00 |
| 90671 |
|
68 |
12 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
12 |
$0.00 |
| 36416 |
|
471 |
215 |
$0.00 |
| 3074F |
|
1,723 |
1,515 |
$0.00 |
| 92551 |
|
943 |
584 |
$0.00 |
| 3075F |
|
153 |
146 |
$0.00 |
| 3079F |
|
558 |
517 |
$0.00 |
| 90647 |
|
64 |
12 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46 |
12 |
$0.00 |
| 3044F |
|
40 |
39 |
$0.00 |
| 82962 |
|
78 |
14 |
$0.00 |
| 3080F |
|
66 |
65 |
$0.00 |